KFF Poll Finds That Most Adults Lack Confidence in Key Health Agencies to Act Independently
(Authors Joel Luther, Hagere Yilma, and Irving Washington for The Kaiser Family Foundation published May 14, 2026) KFF’s latest April
Read More
FDA
Boston Scientific recalls pacemakers after 4 deaths, 2,500 injuries
(By: Mariah Taylor for Becker’s Hospital Review) Boston Scientific issued a recall involving a correction on all 27 Accolade pacemakers
Read MoreFDA launches ‘real-time’ clinical trials
(By: Elizabeth Gregerson for Becker’s Hospital Review) The FDA has launched its first two real-time clinical trials in partnership with
Read More
6 new drugs in shortage
(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to
Read MoreHow to navigate the maze of drug discounts to get the best price
(By Sydney Lupkin for NPR) When TrumpRx launched in February, it joined a chorus of websites claiming to have deals
Read MoreWhat Medicare’s Temporary Program Covering GLP-1s for Obesity Means for Beneficiaries
(By Juliette Cubanski for The Kaiser Family Foundation published March 9, 2026) The Centers for Medicare & Medicaid Services (CMS)
Read MoreThe FDA creates a quicker path for gene therapies
(By Rob Stein for NPR) The Food and Drug Administration Monday unveiled the details of a new policy designed to
Read More
12 drugs in shortage
(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to
Read More
American Action Forum Weighs In on 2026 Health Policy Interest Areas
With drug pricing initiatives pacing the way, American Action Forum (AAF) offers a post today reviewing key changes to the
Read MoreProposed Medicare Advantage rule aims to broaden hemp coverage
(By: Elizabeth Casolo for Becker’s Hospital Review) CMS’s proposed Medicare Advantage rule for 2027 includes more leeway for hemp coverage.
Read More